EG Labo
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Evaluation of the Acceptability and Therapeutic Maintenance After Substitution of Ustekinumab With a Biosimilar (NCT07077681) | EG Labo | 2025-06-02 |
Track EG Labo automatically
Every clearance here is in the API, with alerts when new ones post.